The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer’s disease

BACKGROUND: Apolipoprotein E (APOE) ɛ4 and low cerebrospinal fluid (CSF) amyloid-β42 (Aβ42) levels are predictors for developing Alzheimer’s disease (AD). The results of several studies indicate an interaction between docosahexaenoic acid (DHA) consumption and cognitive outcomes by APOE genotype. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassine, Hussein N., Rawat, Varun, Mack, Wendy J., Quinn, Joseph F., Yurko-Mauro, Karin, Bailey-Hall, Eileen, Aisen, Paul S., Chui, Helena C., Schneider, Lon S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928349/
https://www.ncbi.nlm.nih.gov/pubmed/27358067
http://dx.doi.org/10.1186/s13195-016-0194-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928349/
https://www.ncbi.nlm.nih.gov/pubmed/27358067
http://dx.doi.org/10.1186/s13195-016-0194-x

Ejemplares similares